Antimicrobial resistance and antimicrobial consumption in Europe
|
|
- Josephine Tyler
- 6 years ago
- Views:
Transcription
1 Antimicrobial resistance and antimicrobial consumption in Europe Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Programme Vilnius, 28 November 2017
2 ECDC European Centre for Disease Prevention and Control An agency of the European Union, located in Stockholm, Sweden Founded in 2005; nearly 300 employees in 2015 Mandate to identify, assess and communicate current and emerging threats to human health from communicable diseases European Union (EU) (28) and European Economic Area (EEA) (3) = 31 countries with a total of more than 500 million people
3 Antimicrobial Resistance and Healthcare- Associated Infections (ARHAI) Networks European Antimicrobial Resistance Surveillance Network (EARS-Net) (formerly EARSS, integrated in January 2010) European Surveillance of Antimicrobial Consumption Network (ESAC-Net) (formerly ESAC, integrated in July 2011) Healthcare-Associated Infections surveillance Network (HAI-Net) (formerly HELICS / IPSE, integrated in July 2008)
4 AMR Antimicrobial resistance
5 Antimicrobial resistance: what does it really mean? Several, inter-related compartments of healthcare, (i.e. patients in primary care, hospitals, nursing homes and long-term care facilities), food animals, food, environment Many types of human infections, i.e. respiratory tract, urinary tract, skin and soft tissue, bloodstream, surgical site, related to medical devices, etc.) Many bacteria/microorganisms Many antimicrobials and mechanisms of resistance Patients with infections due to resistant bacteria!
6
7 Burden of antimicrobial resistance (AMR) for the EU/EEA deaths each year in the EU/EEA attributable to 5 multidrug-resistant bacteria 4 main healthcare-associated infections (HAIs) Update: 2018 Source: ECDC, In:
8 Source: ECDC, 2015.
9 Hospitals Food animals Photo: US Dept. of Agriculture Photo: Luis García
10 2 nd Joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA) Report Source: ECDC, EFSA & EMA, EFSA Journal, 27 July ECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals Humans + Animals = One Health
11 Biomass-corrected antimicrobial consumption in humans and animals, EU/EEA, 2014 Source: ECDC, EFSA & EMA, EFSA Journal, 27 July Humans: 124 mg/kg (range: mg/kg) Animals: 152 mg/kg (range: mg/kg) * Humans: community consumption only
12 Biomass-corrected consumption of selected antimicrobial groups in humans and animals, EU/EEA, rd- and 4th-generation cephalosporins Fluoroquinolones and other quinolones Humans Animals Source: ECDC, EFSA & EMA, EFSA Journal, 27 July * Humans: community consumption only
13 Joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA): example Poultry Quinolone consumption and probability of resistance to quinolones in Campylobacter jejuni from poultry, EU/EEA, 2014 OR = 2.71 [ ], p < Each dot represent one country. Source: EFSA Journal, 27 July 2017.
14 Community
15 Defined daily doses (DDD) per 1000 inh. and per day Packages per 1000 inh. and per day Sweden Sweden Denmark Estonia Finland Norway Finland * Total care data, including the hospital sector. Reimbursement data (i.e. not including consumption without a prescription and other non-reimbursed courses). Spain Luxembourg Greece Consumption of antibiotics for systemic use (ATC group J01) in the community, EU/EEA, Source: ESAC-Net, The symbols and indicate a significant increasing or decreasing trend for the period , respectively.
16 Streptococcus pneumoniae: percentage of invasive isolates not susceptible to macrolides; EU/EEA, 2015 Update with 2016 data: 15 Nov Source: EARS-Net, 2016 The symbols and indicate a significant increasing or decreasing trend for the period , respectively. These trends were calculated on laboratories that consistently reported during this period.
17 Escherichia coli: percentage of invasive isolates resistant to third-generation cephalosporins; EU/EEA, 2015 Source: EARS-Net, 2016 The symbols and indicate a significant increasing or decreasing trend for the period , respectively. These trends were calculated on laboratories that consistently reported during this period.
18 Escherichia coli: percentage of invasive isolates resistant to fluoroquinolones; EU/EEA, 2015 Source: EARS-Net, 2016 The symbols and indicate a significant increasing or decreasing trend for the period , respectively. These trends were calculated on laboratories that consistently reported during this period.
19 Joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA): Results of partial least square path modeling (PLS-PM) of fluoroquinolone consumption and fluoroquinoloneresistant Escherichia coli Source: EFSA Journal, 27 July 2017.
20 Compartments of antimicrobial resistance H R E. coli HA-MRSA R Enterobacter R Klebsiella pneumoniae Clostridium difficile R Pseudomonas aeruginosa R Acinetobacter baumannii R Strep. pneumoniae R Salmonella R Campylobacter R E. coli CA-MRSA R Strep. pyogenes R Haem. influenzae R Salmonella R Campylobacter R E. coli LA-MRSA (mostly CC398)
21 Hospitals Photo: Luis García
22 Comparing the burden of healthcareassociated infections (HAIs) with other infectious diseases (BCoDE project 2015) Healthcare-associated infections account for twice the burden of 31 other infectious diseases Burden of HAIs * Burden of 5 top ranking infectious diseases from BCoDE ** HA, Healthcare-associated; DALYs: Disability-Adjusted Life Years Source: *Cassini A, et al. PLoS Med 2016;13(10):e (18 October 2016) ** Cassini A, et al. PLoS Med (submitted).
23 Healthcare-associated infections, antimicrobial resistance: Overlapping, but not identical Healthcareassociated infections Antimicrobial resistance Community-acquired infections
24 Staphylococcus aureus: % of invasive isolates with resistance to meticillin (MRSA), EU/EEA, 2013 & Source: EARS-Net, The symbols and indicate a significant increasing or decreasing trend for the period , respectively. These trends were calculated on laboratories that consistently reported during this period.
25 Klebsiella pneumoniae: % of invasive isolates with combined resistance* EU/EEA, 2013 & *Third-generation cephalosporins, fluoroquinolones and aminoglycosides 2016 Source: EARS-Net, The symbols and indicate a significant increasing or decreasing trend for the period , respectively. These trends were calculated on laboratories that consistently reported during this period.
26 Klebsiella pneumoniae: % of invasive isolates with resistance to carbapenems EU/EEA, 2013 & Source: EARS-Net, The symbols and indicate a significant increasing or decreasing trend for the period , respectively. These trends were calculated on laboratories that consistently reported during this period.
27 Source: EARS-Net and CAESAR, *European Health Information Gateway ( Enerobacteriaceae: carbapenem resistance (%), Europe*, 2016 E. coli K. pneumoniae
28 Carbapenem-resistant infections: a challenge for appropriate patient therapy Courtesy: C. Giske. Karolinska University Hospital, Stockholm, Swede.n Photo:
29 Mohammed (United Kingdom)
30 Joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA): example Humans Carbapenem consumption and probability of resistance to carbapenems in invasive Klebsiella pneumoniae from humans, EU/EEA, 2015 OR = 1.23 [95% CI: ], p = Each dot represent one country. Source: EFSA Journal, 27 July 2017.
31 Consumption of last-line antibiotics in the hospital sector, EU/EEA, Carbapenems (DDD per 1000 inh. and per day) Polymyxins (mainly colistin) (DDD per 1000 inh. and per day) Bulgaria Latvia Hungary Lithuania Slovakia Romania Estonia Bulgaria Denmark Ireland * Cyprus and Romania: total care data, including consumption in the community. These data were not used to calculate the EU/EEA populationweighted average. Croatia France Slovenia Hungary Malta (a) Finland: data include consumption in remote primary healthcare centres and nursing homes. (b) Portugal: data relate to public hospitals only. Malta Cyprus Portugal (b) Romania Italy Slovakia Greece Source: ESAC-Net, The symbols and indicate a significant increasing or decreasing trend for the period , respectively.
32 Klebsiella pneumoniae: % of invasive isolates with combined resistance to carbapenems and colistin, EU/EEA, Source: EARS-Net, 2017 All isolates tested for carbapenem susceptibility were included in the denominator to limit the effect of sequential testing.
33 Pandrug-resistant infections: an hypothetical challenge for Europe? Istockphoto
34 Outbreak of pandrug-resistant VIM-1 Providencia stuartii, Sept.-Nov Source: Douka E, et al. Int J Antimicrob Agents 2015;48:533-6.
35 Examples Mycobacterium chimaera cardiovascular infections linked to heater-cooler devices Candida auris infection optra (transferable oxazolidinone and chloramphenicol resistance)
36 Modern medicine: not possible without effective antibiotics Hip / knee replacement Organ transplant Cancer chemotherapy Intensive care Care of preterm babies
37 Main actions to prevent and control antimicrobial resistance (AMR) New antimicrobial agents (with a novel mechanism of action, research, development) Prudent use of antimicrobial agents (only when needed, correct dose, correct dose intervals, correct duration) Infection prevention and control (hand hygiene, screening, isolation)
38 EU One Health Action Plan against Antimicrobial Resistance (29 June 2017)
39 EU Guidelines for the prudent use of antimicrobials in human health (June 2017)
40
41
42 Country visits to discuss antimicrobial resistance (AMR) issues, As of 28 November 2017 Done Planned (invitation received) * Discussed Jointly with DG SANTE/F Based on Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC) Reports (observations, conclusions, suggestions, examples of best practice) 23 EU Member States and 1 EU enlargement country (see map) 5 follow-up visits (Greece 2 and Hungary 2, Malta) 2018: 6 visits * jointly with DG SANTE/F5, in a One Health perspective Source: ECDC, ** *
43 ECDC rapid risk assessments
44
45 Source: ECDC,
46 Infection prevention and control measures and tools to prevent entry of carbapenem-resistant Enterobacteriaceae (CRE) into healthcare settings: ECDC guidance Core measures Profile for at risk patients who require supplemental measures Preliminary supplemental measures (at admission, for at risk patients) Supplemental measures (for confirmed CRE-positive patients) Source: Magiorakos et al. Antimicrob Resist Infect Control (15 November 2017).
47
48
49 A forward look into 2018 Burden of antimicrobial resistance (AMR) for the EU/EEA (Q2 2018) Annual update on AMR and antimicrobial consumption in humans in the EU/EEA (November 2018) ECDC point prevalence surveys of HAIs, AMR and antimicrobial use in European acute care hospitals and in long-term care facilities, (ECDC publications, November 2018) Launch of project on whole genome sequencing (WGS)-based surveillance of carbapenem- and/or colistin-resistant Enterobacteriaceae (EURGen-Net)
50 18 November 2017 EU event, Brussels, 15 November Website: Facebook: EAAD.EU (#EAAD) Global Twitter: #AntibioticResistance NOVEMBER 2017
AMR epidemiological situation: ECDC update
One Health Network on Antimicrobial Resistance (AMR) AMR epidemiological situation: ECDC update Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI)
More informationAntimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report
Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationPrevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices
Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013
ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013 What is the European Union? 27 Member States 24 official languages
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationAntimicrobial resistance (EARS-Net)
SURVEILLANCE REPORT Annual Epidemiological Report for 2014 Antimicrobial resistance (EARS-Net) Key facts Over the last four years (2011 to 2014), the percentages of Klebsiella pneumoniae resistant to fluoroquinolones,
More informationEuropean Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe
European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe Dominique L. Monnet, Head of Disease Programme, Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Joint
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
More informationStratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationEuropean Medicines Agency role and experience on antimicrobial resistance
European Medicines Agency role and experience on antimicrobial resistance Regional Training Workshop on Antimicrobial Resistance (AMR) Responding to the global challenge of AMR threats: toward a one health
More informationThe threat of multidrug-resistant microorganisms and how to deal with it in Europe
The threat of multidrug-resistant microorganisms and how to deal with it in Europe Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationStratégies et actions au niveau européen et international: populations humaines
Stratégies et actions au niveau européen et international: populations humaines Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationThe challenge of growing resistance
EXECUTIVE SUMMARY Around 2.4 million people could die in Europe, North America and Australia between 2015-2050 due to superbug infections unless more is done to stem antibiotic resistance. However, three
More informationUpdate on European Agencies activities in the field of AMR
Update on European Agencies activities in the field of AMR R. M. Peran (EMA) D. Plachouras (ECDC) P.-A. Belœil (EFSA) European AMR One Health Network Meeting 26 October 2018, 10:00 17:00 Conference Center
More informationAntimicrobial consumption
Antimicrobial consumption Annual Epidemiological Report for 2017 Key facts Twenty-seven countries, comprising 25 EU Member States and two EEA countries (Iceland and Norway) reported data on antimicrobial
More informationAntimicrobial consumption
SURVEILLANCE REPORT Annual Epidemiological Report for 2016 Antimicrobial consumption Key facts Twenty-nine countries, including 27 EU Member States and two EEA countries (Iceland and Norway) reported data
More informationECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials
ECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials P.-A. Belœil (EFSA) and D. Monnet (ECDC) One Health Network on Antimicrobial Resistance
More informationQuelle politique antibiotique pour l Europe? Dominique L. Monnet
Quelle politique antibiotique pour l Europe? Dominique L. Monnet National Center for Antimicrobials & Infection Control Statens Serum Institut, Copenhagen, Denmark Opinion of the Section for Protection
More informationEFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA
EFSA s activities on Antimicrobial resistance in the food chain Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA EFSA IS The reference body for risk assessment of food and feed in the European Union. Its
More informationInitiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector Niels Frimodt-Møller Professor, MD DMSc Dept. of Clinical Microbiology Hvidovre Hospital, Copenhagen,
More informationAntimicrobial Resistance. Tackling the Burden in the European Union. Briefing note for EU/EEA countries
Antimicrobial Resistance Tackling the Burden in the European Union Briefing note for EU/EEA countries Antimicrobial Resistance Tackling the Burden in the European Union Contents Key messages 03 Use of
More informationSurveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe
Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe Carl Suetens, ECDC Presented by Håkan Hanberger ecdc.europa.eu Message/Questions from C Suetens to Workshop 7, MIE2009
More informationProf. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons
What are the consequences of rising antibiotic resistance for Sweden? Prof. Otto Cars Chairman The Swedish Strategic programme against antibiotic resistance (Strama) We are overconsuming a global resource
More informationPolitique du bon usage des antibiotiques: état des lieux et perspectives en Europe
Politique du bon usage des antibiotiques: état des lieux et perspectives en Europe Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationEFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.
EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication. Dr. Ernesto Liebana BIOHAZ Team Leader European Food Safety Authority (EFSA) EFSA
More informationCampylobacter infections in EU/EEA and related AMR
Campylobacter infections in EU/EEA and related AMR Therese Westrell, ECDC EURL Campylobacter workshop, Uppsala, Sweden, 9 October 2018 Zoonoses Zoonotic infections in the EU, 2016 Campylobacteriosis (N
More informationIntegrated Analysis of Data on Resistance and Antimicrobial Consumption from the Human and Animal Sectors in Europe The JIACRA Report
Integrated Analysis of Data on Resistance and Consumption from the Human and Animal Sectors in Europe The JIACRA Report Pierre-Alexandre Beloeil (EFSA), on behalf of the JIACRA expert working group BfR-Symposium
More informationWHO global and regional activities on AMR and collaboration with partner organisations
WHO global and regional activities on AMR and collaboration with partner organisations Dr Danilo Lo Fo Wong Programme Manager for Control of Antimicrobial Resistance Building the AMR momentum 2011 WHO/Europe
More informationA web-based interactive tool to explore antibiotic resistance and consumption via maps and charts
http://resistancemap.cddep.org A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts CDDEP first developed ResistanceMap in 21. The new ResistanceMap now includes
More informationEuropean challenges on antimicrobial resistance from a one health perspective Danish EU Presidency meeting, Copenhagen, 14 March 2012
European challenges on antimicrobial resistance from a one health perspective Danish EU Presidency meeting, Copenhagen, 14 March 2012 Your Royal Highness Crown Princess Mary, Ministers, Distinguished guests,
More informationStop overuse of antibiotics in humans rational use
Stop overuse of antibiotics in humans rational use Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections (ARHAI) European Centre
More informationConsumption of antibiotics in hospitals. Antimicrobial stewardship.
Consumption of antibiotics in hospitals. Antimicrobial stewardship. Inge C. Gyssens MD PhD Radboud university medical center, Nijmegen, The Netherlands Hasselt University, Belgium 1. Antibiotic use in
More informationThe Commission activities on AMR (focus on zoonotic issues)
The Commission activities on AMR (focus on zoonotic issues) R.M. Peran i Sala European Commission, DG SANCO London, 15.09.2011 1. DG SANCO and AMR High priority status given on AMR in DG SANCO EU Commission
More informationAntibiotic resistance: the rise of the superbugs
Antibiotic resistance: the rise of the superbugs Allen Cheng Associate Professor of Infectious Diseases Epidemiology, Alfred Health; Monash University About me Specialist in infectious diseases Head, Infection
More informationrates adjusted for age, sex, infection subclass, and type of antibiotic treatment used) by British Medical Journal Publishing Group
Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis Craig J Currie BMJ 2014;349:g5493 23 September 2014 More than one in 10 initial antibiotic monotherapies
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationEuropean Antibiotic Awareness Day
Initiating a pan-european health campaign - experiences from setting up the European Antibiotic Awareness Day Dr Ülla-Karin Nurm Head of Public Health Development Section, Public Health Capacity and Communication
More informationSCIENTIFIC REPORT. Abstract
SCIENTIFIC REPORT APPROVED: 28 June 2017 doi: 10.2903/j.efsa.2017.4872 ECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial
More informationEU Health Priorities. Jurate Svarcaite Secretary General PGEU
EU Health Priorities Jurate Svarcaite Secretary General PGEU Members: Professional Bodies & Pharmacists Associations 2016: 33 Countries Austria Belgium Bulgaria Croatia Cyprus Czech Rep Denmark Estonia
More informationThe evolutionary epidemiology of antibiotic resistance evolution
The evolutionary epidemiology of antibiotic resistance evolution François Blanquart, CNRS Stochastic Models for the Inference of Life Evolution CIRB Collège de France Quantitative Evolutionary Microbiology
More informationEFSA s activities on Antimicrobial Resistance
EFSA s activities on Antimicrobial Resistance CRL-AR, Copenhagen 23 April 2009 Annual Workshop of CRL - AR 1 Efsa s Role and Activities on AMR Scientific advices Analyses of data on AR submitted by MSs
More informationSECOND REPORT FROM THE COMMISSION TO THE COUNCIL
SECOND REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION (2002/77/EC) ON THE PRUDENT USE OF ANTIMICROBIAL AGENTS IN HUMAN
More informationZoonoses in the EU and global context
Zoonoses in the EU and global context Conference "One world One health. Zoonoses and good practice" 16 October 2018 Vilnius, Lithuania Ángela Bolufer de Gea Unit G4 - Food hygiene Directorate G - Crisis
More informationMISSION REPORT. ECDC country visit to Spain to discuss antimicrobial resistance issues February
MISSION REPORT ECDC country visit to Spain to discuss antimicrobial resistance issues 15-19 February 2016 www.ecdc.europa.eu ECDC MISSION REPORT ECDC country visit to Spain to discuss antimicrobial resistance
More informationby author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010
EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010 Gunnar Kahlmeter Chairman of EUCAST Terms and acronyms AST Antimicrobial Susceptibility Testing MIC Minimum Inhibitory
More informationImpact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital
Impact of Antimicrobial Resistance on Human Health Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital AMR in Foodchain Conference, UCD, Dec 2014 Sir Patrick Dun s Hospital
More informationMRSA in the United Kingdom status quo and future developments
MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L
More informationHealth Service Executive Parkgate St. Business Centre, Dublin 8 Tel:
Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: 01 635 2500 www.hse.ie Health Service Executive Oak House, Millennium Park, Naas, Co. Kildare Tel: 045 880 400 www.hse.ie The prevention
More informationEuropean poultry industry trends
European poultry industry trends November 5 th 2014, County Monaghan Dr. Aline Veauthier & Prof. Dr. H.-W. Windhorst (WING, University of Vechta) 1 Agenda The European Chicken Meat Market - The global
More informationTECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017
TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017 www.ecdc.europa.eu ECDC TECHNICAL REPORT External quality
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationThe European AMR Challenge - strategic views from the human perspective -
The European AMR Challenge - strategic views from the human perspective - World Health Organization Regional Office for Europe Dr Danilo Lo Fo Wong Senior Adviser on Antimicrobial Resistance Division of
More informationECDC country visit to Luxembourg to discuss antimicrobial resistance issues
MISSION REPORT ECDC country visit to Luxembourg to discuss antimicrobial resistance issues 29 May-2 June 2017 www.ecdc.europa.eu ECDC MISSION REPORT ECDC country visit to Luxembourg to discuss antimicrobial
More informationVaccination as a potential strategy to combat Antimicrobial Resistance in the elderly
Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption
More informationVeterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013
Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013 Mario Nagtzaam, SANCO D6 Political commitments as to addressing AMR
More informationCouncil Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting
COUNCIL OF THE EUROPEAN UNION Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting Luxembourg, 10 June 2008 The Council adopted
More informationHSE - Health Protection Surveillance Centre Surveillance of Antimicrobial Consumption in Ireland
Surveillance of Antimicrobial Consumption in Ireland Ajay Oza A European Study on the Relationship between Antimicrobial Use and Antimicrobial Resistance (1998-1999) Bronzwaer et al 2002 Emerging Infectious
More informationThe European road map against antimicrobial resistance
The European road map against antimicrobial resistance (a changing paradigm for drug discovery and development?) Paul M. Tulkens*, MD, PhD Cellular and Molecular Pharmacology Louvain Drug Research Institute
More informationWHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health
New WHO report provides the most comprehensive picture of antibiotic resistance to date, with data from 114 countries 30 APRIL 2014 GENEVA - A new report by WHO its first to look at antimicrobial resistance,
More informationCOMMISSION STAFF WORKING DOCUMENT. Evaluation of the Action Plan against the rising threats from antimicrobial resistance
EUROPEAN COMMISSION Brussels, 24.10.2016 SWD(2016) 347 final COMMISSION STAFF WORKING DOCUMENT Evaluation of the Action Plan against the rising threats from antimicrobial resistance EN EN Contents 1. Introduction...
More informationChanging patterns of poultry production in the European Union
Chapter 2 Changing patterns of poultry production in the European Union H-W. Windhorst Abstract The EU (27) is one of the leading global regions in egg and poultry meat production. Production is, however,
More informationMISSION REPORT. ECDC country visit to Malta to discuss antimicrobial resistance issues. 3-7 July
MISSION REPORT ECDC country visit to Malta to discuss antimicrobial resistance issues 3-7 July 2017 www.ecdc.europa.eu ECDC MISSION REPORT ECDC country visit to Malta to discuss antimicrobial resistance
More informationImplementing Antibiotic Stewardship in Rural and Critical Access Hospitals
National Center for Emerging and Zoonotic Infectious Diseases Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals Denise Cardo, MD Director, Division of Healthcare Quality Promotion,
More informationGlobal action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR) Challenges on the global and regional levels Zsuzsanna Jakab WHO Regional Director for Europe 13 November support the WHO 2014, global action
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationEvaluation of EU strategy to combat AMR
Evaluation of EU strategy to combat AMR Advisory Group of the Food Chain 30 April 2015 Martial Plantady Legislative officer DDG2.G4: Food, Alert Systems & Training DG Health and Food Safety Antimicrobial
More informationEU strategy to fight against Antimicrobial Resistance
EU strategy to fight against Antimicrobial Resistance OECD workshop on the Economics of Antimicrobial Use in the Livestock Sector and Development of Antimicrobial Resistance Paris, 12 October 2015 Martial
More informationHow do people obtain antibiotics in European countries: an overview
How do people obtain antibiotics in European countries: an overview Dominique L. Monnet, Programme Coordinator Senior Expert, Scientific Advice Unit & the National Antimicrobial Resistance Focal Points
More informationESVAC (European Surveillance of Veterinary Antimicrobial Consumption)
ESVAC (European Surveillance of Veterinary Antimicrobial Consumption) Present and future activities 60th Meeting of the EFSA advisory forum Presented J. Torren, Scientific Administrator, Animal and Public
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22 December 2005 COM (2005) 0684 REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION
More informationAntimicrobial Stewardship: efective implementation for improved clinical outcomes
The Challenge of MDR and XDR infections; Barcelona September 2018 Antimicrobial Stewardship: efective implementation for improved clinical outcomes José Miguel Cisneros Herreros Infectious Diseases Department
More information1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection
Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection
More informationEU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play
EU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play Rosa M. Peran i Sala Policy Officer AMR Coordination EC Action Plan against AMR Animal Health Advisory Committee
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health and food audits and analysis REFERENCES: ECDC, MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; 2017 DG(SANTE)/2017-6248 EXECUTIVE SUMMARY
More informationSpecial Eurobarometer 478. Summary. Antimicrobial Resistance
Antimicrobial Resistance Survey requested by the European Commission, Directorate-General for Health and Food Safety and co-ordinated by the Directorate-General for Communication This document does not
More informationSURVEILLANCE REPORT. Surveillance of antimicrobial consumption in Europe
SURVEILLANCE REPORT Surveillance of antimicrobial consumption in Europe 2013-2014 www.ecdc.europa.eu ECDC SURVEILLANCE REPORT Surveillance of antimicrobial consumption in Europe 2013 2014 This report of
More informationANTIMICROBIAL STEWARDSHIP
ANTIMICROBIAL STEWARDSHIP Australian Pig Veterinarians Annual Conference 11-12 September, 2017 Stephen Page Advanced Veterinary Therapeutics swp@advet.com.au OUTLINE Importance of AMR Antimicrobial use
More informationSalmonella monitoring data, food-borne outbreaks and antimicrobial resistance data for 2014 in the European Union
Salmonella monitoring data, food-borne outbreaks and antimicrobial resistance data for 2014 in the European Union Valentina Rizzi BIOMO team, BIOCONTAM Unit, EFSA 21 st EURL-Salmonella workshop 9 June
More informationMISSION REPORT. ECDC country visit to Belgium to discuss antimicrobial resistance issues November
MISSION REPORT ECDC country visit to Belgium to discuss antimicrobial resistance issues 20-24 November 2017 www.ecdc.europa.eu ECDC MISSION REPORT ECDC country visit to Belgium to discuss antimicrobial
More informationAntibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011
Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond
More informationMISSION REPORT. ECDC country visit to Norway to discuss antimicrobial resistance issues March
MISSION REPORT ECDC country visit to Norway to discuss antimicrobial resistance issues 12-16 March 2018 www.ecdc.europa.eu ECDC MISSION REPORT ECDC country visit to Norway to discuss antimicrobial issues
More informationAntimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The
Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr Nils Anders Tegnell, Director, The Public Health Agency of Sweden The Global Challenge Antibiotics
More informationEMA advice on the impact of the use of antibiotics on public and animal health: Potential impact on the authorisation of antimicrobials
EMA advice on the impact of the use of antibiotics on public and animal health: Potential impact on the authorisation of antimicrobials Helen Jukes, CVMP member EMA/IFAH-Europe Info Day, 12 March 2015
More informationThe UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England
The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England Chief Medical Officer - Annual Report 2013 Antimicrobial resistance poses catastrophic
More informationOECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division
OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH Michele Cecchini OECD Health Division Antimicrobial Resistance is a Global Threat Modern medicine and surgery
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationCarbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S
Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S CRE Enterobacteriaceae (Gram Negative Bacilli) Citrobacter species Escherichia coli***
More informationAn agency of the European Union
An agency of the European Union Human medicines in 23 Research and development 473 overall number of scientific advice and protocol assistance requests received in 23
More informationImplementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials
Implementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials Dr. Sasi Jaroenpoj, D.V.M Head of Veterinary Products and AMR
More informationTestimony of the Natural Resources Defense Council on Senate Bill 785
Testimony of the Natural Resources Defense Council on Senate Bill 785 Senate Committee on Healthcare March 16, 2017 Position: Support with -1 amendments I thank you for the opportunity to address the senate
More informationDraft ESVAC Vision and Strategy
1 2 3 7 April 2016 EMA/326299/2015 Veterinary Medicines Division 4 5 6 Draft Agreed by the ESVAC network 29 March 2016 Adopted by ESVAC 31 March 2016 Start of public consultation 7 April 2016 End of consultation
More informationNorwegian policies to address antimicrobial resistance
Norwegian policies to address antimicrobial resistance Frode Forland, Specialist Director, Division of Infectious Control and Environmental Health, Norwegian Institute of Public Health Karianne Johansen,
More informationEC Workshop on scientific advice from AMEG
EC Workshop on scientific advice from AMEG Brussels, 26 Nov 2015 Session 2: Antibiotic Categorisation AMEG Q2 Karolina Törneke / Helen Jukes Liability disclaimer: The views or positions expressed in this
More informationMISSION REPORT. ECDC country visit to Italy to discuss antimicrobial resistance issues January
MISSION REPORT ECDC country visit to Italy to discuss antimicrobial resistance issues 9-13 January 2017 www.ecdc.europa.eu ECDC MISSION REPORT ECDC country visit to Italy to discuss antimicrobial resistance
More information3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats
Antibiotics --When Less is More Ralph Gonzales, MD, MSPH Associate Dean, Clinical Innovation School of Medicine VP, Clinical Innovation, UCSF Health Most Urgent Threats Serious Threats Multidrug-Resistant
More informationHuman health impacts of antibiotic use in animal agriculture
Human health impacts of antibiotic use in animal agriculture Beliefs, opinions, and evidence Peter Davies BVSc, PhD College of Veterinary Medicine, University of Minnesota, USA Terminology Antibiotic Compound
More informationThe Role of the European Food Safety Authority (EFSA) in the Fight against Antimicrobial Resistance (AMR)
GENERAL INTEREST PAPER The Role of the European Food Safety Authority (EFSA) in the Fight against Antimicrobial Resistance (AMR) Pietro Stella, 1* Pierre-Alexandre Beloeil, 1 Beatriz Guerra, 1 Marta Hugas
More informationW O s trategi g c i actio i n o n pl p a l n n on o ant n ib i i b o i t o ic i resis i tanc n e in i n Eu E r u op o e p
WHO strategic action plan on antibiotic resista ance in Europe Strengthening g surveillance Dr Danilo Lo Fo Wong Senior Adv viser AMR Backg ground AMR costs money, livelihoods and lives, and undermines
More information